Investigational Drug Services and medication safety

PLEASE NOTE:   Posts made to this forum should not be considered as the expressed opinions of, nor should be considered endorsed by, the Medication Safety Officer’s Society (MSOS) or the Institute for Safe Medication Practices (ISMP). 

Make sure your email is up-to-date
In order to continue to receive updates from MSOS, as well as forum posts and other valuable information as a member of MSOS, please be sure to update your email address with us, whenever it changes. If you need assistance doing so, please send an email to jrufo@ismp.org. 

2 posts / 0 new
Log in or register to post comments
Last post
Mon, 06/13/2016 - 12:12
#1
Bridget Gegorski
Bridget Gegorski's picture
Offline
Last seen: 10 months 2 weeks ago
Joined: 09/19/2014 - 14:47
Investigational Drug Services and medication safety

Hello,

I am trying to gain some insight from other Medication Safety Officers regarding how they interact with the IRB and investigational drug services.

Typically errors that occur in this space are documented as study variances and are addressed by the IRB. Do any of your sites also ask that these errors be reported internally to the hospital's voluntary error reporting system for further review?

Thank you in advance for your responses!

Sincerely,

Bridget Gegorski, Pharm.D.
Medication Safety Officer
University Hospitals Office: 216-983-1307
11100 Euclid Ave Fax: 216-844-3052
Cleveland, Ohio 44106 Mail Stop: WRN 5006
Bridget.Gegorski@UHHospitals.org

Top